Relationship between warfarin dosage and international normalized ratio: a dose–response analysis and evaluation based on multicenter data-Reference-Cited by-同舟云学术

Relationship between warfarin dosage and international normalized ratio: a dose–response analysis and evaluation based on multicenter data

Published:2019-04-29 Issue:6 Volume:75 Page:785-794
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:en
Short-container-title:Eur J Clin Pharmacol

Author:

Xue Ling,Zhang Yuzhen,Xie Cheng,Zhou Ling,Liu Linsheng,Zhang Haiyan,Xu Lianhong,Song Hongtao,Lin Meiqin,Qiu Hanfan,Zhu Junrong,Zhu Yubing,Zou Jianjun,Zhuang Wenfang,Xuan Binbin,Chen Yanhong,Fan Yingchao,Wu Di,Shen Zhenya,Miao Liyan

Funder

National Key New Drug Creation Special Programs

Young Scientists Fund

Suzhou Key Laboratory of Drug Clinical Research and Personalized Medicine

People's Livelihood Science and Technology Foundation of Suzhou Science and Technology Bureau

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00228-019-02655-8.pdf

Reference21 articles.

1. International Warfarin Pharmacogenetics C, Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MT, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA (2009) Estimation of the warfarin dose with clinical and pharmacogenetic data. N Engl J Med 360(8):753–764. https://doi.org/10.1056/NEJMoa0809329

2. Gong IY, Tirona RG, Schwarz UI, Crown N, Dresser GK, Larue S, Langlois N, Lazo-Langner A, Zou G, Roden DM, Stein CM, Rodger M, Carrier M, Forgie M, Wells PS, Kim RB (2011) Prospective evaluation of a pharmacogenetics-guided warfarin loading and maintenance dose regimen for initiation of therapy. Blood 118(11):3163–3171. https://doi.org/10.1182/blood-2011-03-345173

3. Limdi NA, Brown TM, Yan Q, Thigpen JL, Shendre A, Liu N, Hill CE, Arnett DK, Beasley TM (2015) Race influences warfarin dose changes associated with genetic factors. Blood 126(4):539–545. https://doi.org/10.1182/blood-2015-02-627042

4. O'Dell KM, Igawa D, Hsin J (2012) New Oral anticoagulants for atrial fibrillation: a review of clinical trials. Clin Ther 34(4):894–901. https://doi.org/10.1016/j.clinthera.2012.01.019

5. Wadhera RK, Russell CE, Piazza G (2014) Warfarin versus novel oral anticoagulants how to choose? Circulation 130(22):E191–E193. https://doi.org/10.1161/Circulationaha.114.010426

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Warfarin–A natural anticoagulant: A review of research trends for precision medication;Phytomedicine;2024-06

2. Impact of VKORC1, CYP2C9, CYP1A2, UGT1A1, and GGCX polymorphisms on warfarin maintenance dose: Exploring a new algorithm in South Chinese patients accept mechanical heart valve replacement;Medicine;2022-07-22

3. External Evaluation of a Bayesian Warfarin Dose Optimization Based on a Kinetic-Pharmacodynamic Model;Biological and Pharmaceutical Bulletin;2022-01-01

4. Safety and Effectiveness of Apixaban in Japanese Patients With Venous Thromboembolism in Clinical Practice　― A Post-Marketing Surveillance ―;Circulation Journal;2021-11-25

5. Genotype‐guided warfarin therapy: Still of only questionable value two decades on;Journal of Clinical Pharmacy and Therapeutics;2020-03-13